<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Pre‐emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer - Uneno, Y - 2022 | Cochrane Library</title> <meta content="Pre‐emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer - Uneno, Y - 2022 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013604.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Pre‐emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer - Uneno, Y - 2022 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013604.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013604.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Pre‐emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer" name="citation_title"/> <meta content="Yu Uneno" name="citation_author"/> <meta content="Graduate School of Medicine, Kyoto University" name="citation_author_institution"/> <meta content="yuuneno@kuhp.kyoto-u.ac.jp" name="citation_author_email"/> <meta content="Haruki Imura" name="citation_author"/> <meta content="School of Public Health in Graduate School of Medicine, Kyoto University" name="citation_author_institution"/> <meta content="Yosuke Makuuchi" name="citation_author"/> <meta content="Graduate School of Medicine, Osaka Metropolitan University" name="citation_author_institution"/> <meta content="Kentaro Tochitani" name="citation_author"/> <meta content="School of Public Health in the Graduate School of Medicine, Kyoto University" name="citation_author_institution"/> <meta content="Norio Watanabe" name="citation_author"/> <meta content="Soseikai General Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD013604.pub2" name="citation_doi"/> <meta content="2022" name="citation_date"/> <meta content="2022/11/28" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013604.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013604.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013604.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Antifungal Agents [adverse effects]; *Febrile Neutropenia [chemically induced, prevention &amp; control]; Invasive Fungal Infections [drug therapy, prevention &amp; control]; *Neoplasms [drug therapy]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013604.pub2&amp;doi=10.1002/14651858.CD013604.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="18M35a5z";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013604\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013604\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013604\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013604\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","ko","th","ms","hr","id","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013604.pub2",title:"Pre\\u2010emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer",firstPublishedDate:"Nov 28, 2022 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013604.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013604.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013604.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013604.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013604.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013604.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;id&quot;,&quot;title&quot;:&quot;Saripati tinjauan sistematik&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013604.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013604.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013604.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013604.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1911 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013604.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/full#CD013604-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/full#CD013604-sec-0070"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/full#CD013604-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/full#CD013604-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/full#CD013604-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/full#CD013604-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/full#CD013604-sec-0041"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/full#CD013604-sec-0064"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/appendices#CD013604-sec-0075"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/supinfo/CD013604StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/supinfo/CD013604StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2022 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Pre‐emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/information#CD013604-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Yu Uneno</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/information#CD013604-cr-0005">Haruki Imura</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/information#CD013604-cr-0006">Yosuke Makuuchi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/information#CD013604-cr-0007">Kentaro Tochitani</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013604.pub2/information#CD013604-cr-0008">Norio Watanabe</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/information/en#CD013604-sec-0082">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 28 November 2022 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013604.pub2">https://doi.org/10.1002/14651858.CD013604.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013604-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013604-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013604-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013604-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013604-abs-0015">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013604-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD013604-abs-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013604-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013604-abs-0001" lang="en"> <section id="CD013604-sec-0001"> <h3 class="title" id="CD013604-sec-0001">Background</h3> <p>Intensive cytotoxic chemotherapy for people with cancer can cause severe and prolonged cytopenia, especially neutropenia, a critical condition that is potentially life‐threatening. When manifested by fever and neutropenia, it is called febrile neutropenia (FN). Invasive fungal disease (IFD) is one of the serious aetiologies of chemotherapy‐induced FN. In pre‐emptive therapy, physicians only initiate antifungal therapy when an invasive fungal infection is detected by a diagnostic test. Compared to empirical antifungal therapy, pre‐emptive therapy may reduce the use of antifungal agents and associated adverse effects, but may increase mortality. The benefits and harms associated with the two treatment strategies have yet to be determined.  </p> </section> <section id="CD013604-sec-0002"> <h3 class="title" id="CD013604-sec-0002">Objectives</h3> <p>To assess the relative efficacy, safety, and impact on antifungal agent use of pre‐emptive versus empirical antifungal therapy in people with cancer who have febrile neutropenia. </p> </section> <section id="CD013604-sec-0003"> <h3 class="title" id="CD013604-sec-0003">Search methods</h3> <p>We searched CENTRAL, MEDLINE Ovid, Embase Ovid, and ClinicalTrials.gov to October 2021. </p> </section> <section id="CD013604-sec-0004"> <h3 class="title" id="CD013604-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) that compared pre‐emptive antifungal therapy with empirical antifungal therapy for people with cancer. </p> </section> <section id="CD013604-sec-0005"> <h3 class="title" id="CD013604-sec-0005">Data collection and analysis</h3> <p>We identified 2257 records from the databases and handsearching. After removing duplicates, screening titles and abstracts, and reviewing full‐text reports, we included seven studies in the review. We evaluated the effects on all‐cause mortality, mortality ascribed to fungal infection, proportion of antifungal agent use (other than prophylactic use), duration of antifungal use (days), invasive fungal infection detection, and adverse effects for the comparison of pre‐emptive versus empirical antifungal therapy. We presented the overall certainty of the evidence for each outcome according to the GRADE approach. </p> </section> <section id="CD013604-sec-0006"> <h3 class="title" id="CD013604-sec-0006">Main results</h3> <p>This review includes 1480 participants from seven randomised controlled trials. Included studies only enroled participants at high risk of FN (e.g. people with haematological malignancy); none of them included participants at low risk (e.g. people with solid tumours).  </p> <p>Low‐certainty evidence suggests there may be little to no difference between pre‐emptive and empirical antifungal treatment for all‐cause mortality (risk ratio (RR) 0.97, 95% confidence interval (CI) 0.72 to 1.30; absolute effect, reduced by 3/1000); and for mortality ascribed to fungal infection (RR 0.92, 95% CI 0.45 to 1.89; absolute effect, reduced by 2/1000). Pre‐emptive therapy may decrease the proportion of antifungal agent used more than empirical therapy (other than prophylactic use; RR 0.71, 95% CI 0.47 to 1.05; absolute effect, reduced by 125/1000; very low‐certainty evidence). Pre‐emptive therapy may reduce the duration of antifungal use more than empirical treatment (mean difference (MD) ‐3.52 days, 95% CI ‐6.99 to ‐0.06, very low‐certainty evidence). Pre‐emptive therapy may increase invasive fungal infection detection compared to empirical treatment (RR 1.70, 95% CI 0.71 to 4.05; absolute effect, increased by 43/1000; very low‐certainty evidence). Although we were unable to pool adverse events in a meta‐analysis, there seemed to be no apparent difference in the frequency or severity of adverse events between groups. </p> <p>Due to the nature of the intervention, none of the seven RCTs could blind participants and personnel related to performance bias. We identified considerable clinical and statistical heterogeneity, which reduced the certainty of the evidence for each outcome. However, the two mortality outcomes had less statistical heterogeneity than other outcomes. </p> </section> <section id="CD013604-sec-0007"> <h3 class="title" id="CD013604-sec-0007">Authors' conclusions</h3> <p>For people with cancer who are at high‐risk of febrile neutropenia, pre‐emptive antifungal therapy may reduce the duration and rate of use of antifungal agents compared to empirical therapy, without increasing over‐all and IFD‐related mortality; but the evidence regarding invasive fungal infection detection and adverse events was inconsistent and uncertain.  </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013604-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013604-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013604-abs-0018">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013604-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013604-abs-0016">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD013604-abs-0011">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/id#CD013604-abs-0012">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013604-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013604-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/th#CD013604-abs-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013604-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD013604-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013604-abs-0002" lang="en"> <h3>Pre‐emptive versus empirical antifungal therapy in people with cancer who have febrile neutropenia </h3> <p>Intensive chemotherapy for people with cancer can cause severe and prolonged cytopenia (lower‐than‐normal number of blood cells), especially neutropenia (lower‐than‐normal white blood cells, which help to fight infection), a critical condition that is potentially life‐threatening. When a person has both fever and neutropenia, it is called febrile neutropenia (FN). Invasive fungal disease (IFD; an infection caused by a fungus) is one of the serious causes of chemotherapy‐induced FN.  </p> <p>There are two treatment strategies in this situation. In empirical antifungal therapy, an antifungal medicine is given when the doctor first suspects there is a fungal infection (e.g. person still has a fever after four to seven days of antibiotic therapy, or the doctor is still trying to pinpoint the cause of the fever). In pre‐emptive therapy, the doctor uses a series of laboratory screening tests to find what is causing the infection before starting the antifungal medicine.  </p> <p>Compared to empirical therapy, pre‐emptive therapy may reduce the use of antifungal medicines and the adverse effects they can cause, but may increase the number of deaths. The benefits and harms associated with the two treatment strategies have yet to be determined. </p> <p><b>Who will be interested in this review?</b><br/>Healthcare professionals, including clinical oncologists; people with cancer and the people around them. </p> <p><b>What question does this review aim to answer?</b><br/>This systematic review aimed to find and evaluate the evidence for the relative efficacy (how well they work); safety (the number and severity of side effects); and the impact of pre‐emptive versus empirical antifungal therapy on the use of antifungal medicines in people with cancer who have FN. </p> <p><b>Which studies were included in the review?</b><br/>We searched electronic medical databases to find all relevant studies that included adults with cancer who had FN. To be included, the studies had to be randomised controlled trials (RCTs), which means the participants were divided at random (by chance alone), to receive either empirical or pre‐emptive antifungal medicine (last search October 2021). We included seven studies, involving 1480 people, which compared empirical and pre‐emptive antifungal treatment strategies.  </p> <p><b>What does the evidence from the review tell us?</b><br/>For people with cancer and febrile neutropenia, there may be little or no difference in the number of deaths between those receiving pre‐emptive and those receiving empirical antifungal therapy. Pre‐emptive therapy may increase the rate of identifying IFD, and reduce the duration and rate of use of antifungal medicines, but has not been shown to reduce adverse events. The certainty of the evidence ranged from very low to low; at best, our confidence in the effect estimate is limited. </p> <p><b> What should happen next?</b><br/>Pre‐emptive therapy may be a promising treatment method for people with cancer who have FN. Since the trials reported different treatments, standardising treatment protocols will help to determine a more valid evaluation of the treatment effects. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013604-sec-0070" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013604-sec-0070"></div> <h3 class="title" id="CD013604-sec-0071">Implications for practice</h3> <section id="CD013604-sec-0071"> <p>For people with cancer and high‐risk febrile neutropenia, pre‐emptive antifungal therapy may reduce the duration and rate of use of antifungal agents without deteriorating all‐cause and invasive fungal disease‐related mortality, compared to empirical therapy. But the evidence regarding invasive fungal infection detection and adverse events was inconsistent and uncertain.  </p> </section> <h3 class="title" id="CD013604-sec-0072">Implications for research</h3> <section id="CD013604-sec-0072"> <p>Future research should focus on:</p> <p> <ul id="CD013604-list-0014"> <li> <p>Developing a standardised protocol for pre‐emptive antifungal therapy;</p> </li> <li> <p>Defining the target population for pre‐emptive antifungal therapy, reporting the detailed and various subgroup analysis; </p> </li> <li> <p>Developing a consensus on the clinically optimal evaluation period for mortality and other relevant outcomes. </p> </li> </ul> </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013604-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013604-sec-0008"></div> <div class="table" id="CD013604-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Pre‐emptive antifungal therapy versus empirical antifungal therapy</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Pre‐emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population</b>: people with cancer who have febrile neutropenia </p> <p><b>Settings</b>: intensive cytotoxic chemotherapy at hospital </p> <p><b>Intervention</b>: pre‐emptive antifungal therapy </p> <p><b>Comparison</b>: empirical antifungal therapy </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcome</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk with empirical antifungal therapy</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk with pre‐emptive antifungal therapy</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>108 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>105 per 1000 (78 to 141)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.97 (0.72 to 1.30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1459<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕◯◯</p> <p>low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality ascribed to fungal infection</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>27 per 1000 (13 to 55)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.92 (0.45 to 1.89)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1407<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕◯◯</p> <p>low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Proportion of antifungal agent use (other than prophylactic use)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>431 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>306 per 1000 (202 to 452)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.71 (0.47 to 1.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1480<br/>(7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕◯◯◯</p> <p>very low<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Duration of antifungal use</b>  </p> <p><i>(days)</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of antifungal use ranged across control groups from</p> <p>7 to 20 days</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of antifungal use ranged across intervention groups from</p> <p>4.5 to 13.8 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐3.52 (‐6.99 to ‐0.66)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>764<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕◯◯◯</p> <p>very low<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Invasive fungal infection detection</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>60 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>103 per 1000 (43 to 244)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.70 (0.71 to 4.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1480<br/>(7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕◯◯◯</p> <p>very low<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD013604-bbs2-0004" title="HebartH ,  KlingsporL ,  KlingebielT ,  LoefflerJ ,  TollemarJ ,  LjungmanP ,  et al. A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT. Bone Marrow Transplant2009;43(7):553-61. [DOI: 10.1038/bmt.2008.355]">Hebart 2009</a> reported 39/152 (25.7%) cases of nephrotoxicity in the pre‐emptive therapy group, and 28/92 cases (30.4%) in the empirical therapy group.  </p> <p><a href="./references#CD013604-bbs2-0005" title="MorrisseyCO , ChenSC , SorrellTC , MillikenS , BardyPG , BradstockKF , et al,  Australasian Leukaemia Lymphoma Group and the Australia and New Zealand Mycology Interest Group. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. Lancet Infectious Diseases2013;13(6):519-28. [DOI: 10.1016/S1473-3099(13)70076-8]">Morrissey 2013</a> reported 12/118 (10%) cases of hepatotoxicity in the pre‐emptive therapy group, and 21/122 (17%; P = 0.11) cases in the empirical therapy group; and 60/118 (51%) cases of nephrotoxicity in the pre‐emptive therapy group, and 52/122 (43%; P = 0.21) cases in the empirical therapy group.  </p> <p><a href="./references#CD013604-bbs2-0003" title="CordonnierC , PautasC , MauryS , VekhoffA , FarhatH , SuarezF , et al. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial. Clinical Infectious Diseases2009;48(8):1042-51. ">Cordonnier 2009</a> reported the mean decrease in creatinine clearance ± SD was larger in the empirical therapy group (‐8.7 ± 20.8) than in the pre‐emptive therapy group (‐5.8 ± 27.2). Severe adverse events occurred in similar proportions in the two groups.  </p> <p><a href="./references#CD013604-bbs2-0007" title="YuanW ,  RenJ ,  GuoX ,  Xiaoling Guo,  CaiS . Preemptive antifungal therapy for febrile neutropenic hematological malignancy patients in China. Medical Science Monitor2016;22:4226-32. [DOI: 10.12659/msm.897596]">Yuan 2016</a> reported that 1/26 courses (3.8%) of antifungal treatment resulted in adverse events leading to discontinued treatment in the pre‐emptive therapy group, and 2/43 courses (4.7%) resulted in adverse events leading to discontinued treatment in the empirical therapy group (P = 0.874). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1074 </p> <p>(4 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕◯◯◯</p> <p>very low<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the intervention group and the relative effect of the intervention (and its 95% CI). </p> <p>CI: confidence interval; RR: risk ratio; MD, mean difference.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded the certainty of the evidence by two levels. First, since there were no blinded studies, this could lead to considerable risk of bias; second, the clinical heterogeneity of the interventions was a critical factor of indirectness. <br/><sup>b</sup>We downgraded the certainty of the evidence by three levels. First, since there were no blinded studies, this could lead to considerable risk of bias; second, the clinical heterogeneity of the interventions was critical factor of indirectness; third, the results were inconsistent, marked with considerable heterogeneity (I<sup>2</sup> =75% to 88%). <br/><sup>c</sup>We downgraded the certainty of the evidence by three levels. First, since there were no blinded studies, this could lead to considerable risk of bias; second, the clinical heterogeneity of the interventions was critical factor of indirectness; third, meta analysis was not performed.  </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013604-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013604-sec-0009"></div> <section id="CD013604-sec-0010"> <h3 class="title" id="CD013604-sec-0010">Description of the condition</h3> <p>Intensive cytotoxic chemotherapy for people with cancer can cause severe and prolonged cytopenia, especially neutropenia, a critical condition that is potentially life‐threatening (<a href="./references#CD013604-bbs2-0041" title="SmithTJ , BohlkeK , LymanGH , CarsonKR , CrawfordJ , CrossSJ , et al. Recommendations for the use of WBC growth factors: American society of clinical oncology clinical practice guideline update. Journal of Clinical Oncology2015;33(28):3199-212.">Smith 2015</a>). When it is manifested by fever and neutropenia, it is called febrile neutropenia (FN). The fever is defined as a single oral temperature reading that is above 38.3 °C (101 °F), or a temperature above 38.0 °C (100.4 °F) that is sustained for at least one hour. Neutropenia is defined as an absolute neutrophil count (ANC) of 500 cells/mm³ or less, or an ANC that is expected to decrease to less than 500 cells/mm³ during the next 48 hours (<a href="./references#CD013604-bbs2-0022" title="FreifeldAG , BowEJ , SepkowitzKA , BoeckhMJ , ItoJI , MullenCA , et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clinical Infectious Diseases2011;52(4):e56-93.">Freifeld 2011</a>). Incidence rates of chemotherapy‐induced FN are 10% to 50% in people with solid tumours, and more than 80% with haematological malignancies (<a href="./references#CD013604-bbs2-0010" title="Al-TawfiqJA , HinediK , KhairallahH , SaadehB , AbbasiS , NoureenM , et al. Epidemiology and source of infection in patients with febrile neutropenia: a ten-year longitudinal study. Journal of Infection and Public Health2019;12(3):364-6.">Al‐Tawfiq 2019</a>; <a href="./references#CD013604-bbs2-0028" title="KlasterskyJ . Management of fever in neutropenic patients with different risks of complications. Clinical Infectious Diseases2004;39(Suppl 1):S32-7.">Klastersky 2004</a>). </p> <p>Invasive fungal disease (IFD) is one of the serious aetiologies of chemotherapy‐induced FN. It is challenging to diagnose IFD early in the course of FN, due to the low sensitivity and specificity of clinical symptoms (e.g. fever, cough, haemoptysis, maculopapular eruptions, nodules, erythema), and microbiological and radiological diagnostic tests (<a href="./references#CD013604-bbs2-0030" title="MaddyAJ , SanchezN , ShuklaBS , MaderalAD . Dermatological manifestations of fungal infection in patients with febrile neutropaenia: a review of the literature. Mycoses2019;62(9):826-34.">Maddy 2019</a>). Treatment outcomes can potentially result in severe morbidity and mortality when the initiation of therapy is delayed. One autopsy study revealed that 69% of people with a history of prolonged FN had evidence of invasive fungal infections (<a href="./references#CD013604-bbs2-0016" title="ChoSY , ChoiHY . Opportunistic fungal infection among cancer patients. A ten-year autopsy study. American Journal of Clinical Pathology1979;72(4):617-21.">Cho 1979</a>). A more recent report suggested that the incidence rate of IFD, even in people at a high risk, was considered to be 10% or lower; there was considerable variation in the incidence rate among different cancer types (e.g. leukaemia, allogeneic stem cell transplant, etc), countries, and cancer hospitals (<a href="./references#CD013604-bbs2-0032" title="MaertensJA , GirmeniaC , BrüggemannRJ , DuarteRF , KibblerCC , LjungmanP , et al, European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN). European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia. Journal of Antimicrobial Chemotherapy2018;73(12):3221-30.">Maertens 2018</a>). </p> <p>To reduce the morbidity and mortality from IFD, researchers have investigated several antifungal drug strategies. An antifungal treatment strategy is often initiated by giving antifungal drugs prophylactically during chemotherapy. Numerous clinical trials have investigated a prophylactic approach and observed robust efficacy, reducing the risk of IFD and fungal infection‐related mortality (<a href="./references#CD013604-bbs2-0013" title="BowEJ , LaverdiereM , LussierN , RotsteinC , CheangMS , IoannouS . Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials. Cancer2002;94(12):3230-46.">Bow 2002</a>; <a href="./references#CD013604-bbs2-0024" title="GlasmacherA , PrenticeA , GorschluterM , EngelhartS , HahnC , DjulbegovicB , et al. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients. Journal of Clinical Oncology2003;21(24):4615-26.">Glasmacher 2003</a>; <a href="./references#CD013604-bbs2-0039" title="RobenshtokE , Gafter-GviliA , GoldbergE , WeinbergerM , YeshurunM , LeiboviciL , et al. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis. Journal of Clinical Oncology2007;25(34):5471-89.">Robenshtok 2007</a>). Accordingly, the Infectious Diseases Society of America (IDSA) guidelines recommend antifungal prophylactic drugs (A‐1 recommendation) for people with high‐risk FN (<a href="./references#CD013604-bbs2-0022" title="FreifeldAG , BowEJ , SepkowitzKA , BoeckhMJ , ItoJI , MullenCA , et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clinical Infectious Diseases2011;52(4):e56-93.">Freifeld 2011</a>). </p> <p>Alternative antifungal treatment should be considered when fever persists or recurs despite the use of empirical antimicrobial therapy and antifungal prophylaxis. Empirical antifungal therapy refers to the administration of an antifungal agent at the first clinical suspicion of fungal infection (e.g. persistent fever after four to seven days of antibiotic therapy, or in the absence of a definitive diagnosis (<a href="./references#CD013604-bbs2-0015" title="ChenK , WangQ , PleasantsRA , GeL , LiuW , PengK , et al. Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysis. BMC Infectious Diseases2017;17(1):159.">Chen 2017</a>)). In previous clinical trials, empirical therapy showed favourable survival outcomes (<a href="./references#CD013604-bbs2-0020" title="EORTC International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients. American Journal of Medicine1989;86:668-72.">EORTC 1989</a>; <a href="./references#CD013604-bbs2-0037" title="PizzoPA , RobichaudKJ , GillFA , WitebskyFG . Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. American Journal of Medicine1982;72(1):101-11.">Pizzo 1982</a>). This therapy is also strongly recommended (A‐1 recommendation) in the IDSA guidelines (<a href="./references#CD013604-bbs2-0022" title="FreifeldAG , BowEJ , SepkowitzKA , BoeckhMJ , ItoJI , MullenCA , et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clinical Infectious Diseases2011;52(4):e56-93.">Freifeld 2011</a>). However, the practice of empirical administration of antifungal drugs leads to several concerns: possible overuse of antifungal agents, emergence of antifungal resistance, undesirable drug interaction, and adverse effects (i.e. nephrotoxicity and hepatotoxicity (<a href="./references#CD013604-bbs2-0031" title="MaertensJA , NucciM , DonnellyJP . The role of antifungal treatment in hematology. Haematologica2012;97(3):325-7.">Maertens 2012</a>)). </p> <p>To combat these concerns, researchers have developed another approach, called pre‐emptive or presumptive antifungal therapy. Pre‐emptive therapy is generally referred as the treatment that uses antifungal agents only in cases when fungal infection is detected by diagnostic tests, such as imaging tests (e.g. chest X‐ray, chest and sinus computed tomography (CT) scan), rapid sensitive microbiology assays (e.g. β‐D‐glucan, galactomannan antigen, serum <i>Candida spp.</i> or <i>Aspergillus spp.</i> polymerase chain reaction (PCR)), or both (<a href="./references#CD013604-bbs2-0023" title="FungM , KimJ , MartyFM , SchwarzingerM , KooS . Meta-analysis and cost comparison of empirical versus pre-emptive antifungal strategies in hematologic malignancy patients with high-risk febrile neutropenia. PLoS One2015;10(11):e0140930. [DOI: 10.1371/journal.pone.0140930]">Fung 2015</a>). According to the IDSA guidelines, pre‐emptive antifungal management is an acceptable alternative to empirical antifungal therapy in a subset of people with high‐risk neutropenia (<a href="./references#CD013604-bbs2-0022" title="FreifeldAG , BowEJ , SepkowitzKA , BoeckhMJ , ItoJI , MullenCA , et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clinical Infectious Diseases2011;52(4):e56-93.">Freifeld 2011</a>). </p> <p>To date, there has been no examination of the difference between empirical and pre‐emptive administration of antifungal drugs for efficacy, safety, and impact on clinical resource use. The development of novel antifungal prophylactic agents, and the selection of antifungal prophylactic agents also confound efforts to determine the risks (harms) and benefits between the two treatment strategies. </p> </section> <section id="CD013604-sec-0011"> <h3 class="title" id="CD013604-sec-0011">Description of the intervention</h3> <p>Pre‐emptive therapy begins with serial screening, using rapid sensitive microbiology assays, to detect the presence of a putative pathogen or early subclinical infection. Physicians may also use an imaging test to support a diagnosis. Considering that a single diagnostic approach yields less sensitivity, a combination of microbiology assay and imaging studies may be promising for the early diagnosis of fungal infection (<a href="./references#CD013604-bbs2-0011" title="Asano-MoriY , KandaY , OshimaK , KakoS , ShinoharaA , NakasoneH , et al. False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation. Journal of Antimicrobial Chemotherapy2008;61(2):411-6.">Asano‐Mori 2008</a>; <a href="./references#CD013604-bbs2-0021" title="EscuissatoDL , GasparettoEL , MarchioriE , Rocha GdeM , InoueC , PasquiniR , et al. Pulmonary infections after bone marrow transplantation: high-resolution CT findings in 111 patients. American Journal of Roentgenology2005;185(3):608-15.">Escuissato 2005</a>; <a href="./references#CD013604-bbs2-0033" title="MarrKA , LaverdiereM , GugelA , LeisenringW . Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clinical Infectious Diseases2005;40(12):1762-9.">Marr 2005</a>). The combination of these tests leads to the existence of various pre‐emptive therapy protocols. When these tests are positive, antifungal therapy is initiated to avoid progression to an invasive disease. </p> </section> <section id="CD013604-sec-0012"> <h3 class="title" id="CD013604-sec-0012">How the intervention might work</h3> <p>In pre‐emptive therapy, physicians only initiate antifungal therapy when an invasive fungal infection is detected by a diagnostic test. Accordingly, pre‐emptive treatment is expected to decrease the use of antifungal drugs, the emergence of antifungal resistance, undesirable drug interactions, and adverse effects (<a href="./references#CD013604-bbs2-0023" title="FungM , KimJ , MartyFM , SchwarzingerM , KooS . Meta-analysis and cost comparison of empirical versus pre-emptive antifungal strategies in hematologic malignancy patients with high-risk febrile neutropenia. PLoS One2015;10(11):e0140930. [DOI: 10.1371/journal.pone.0140930]">Fung 2015</a>). However, if the initiation of pre‐emptive treatment is delayed, it may lead to life‐threatening situations compared with empirical therapy. </p> </section> <section id="CD013604-sec-0013"> <h3 class="title" id="CD013604-sec-0013">Why it is important to do this review</h3> <p>Compared to empirical therapy, pre‐emptive therapy may reduce the use of antifungal agents and associated adverse effects, but may increase mortality. The benefits and harms associated with the two treatment strategies have yet to be determined. This systematic review aimed to provide a body of evidence regarding the relative efficacy, safety, and impact of antifungal agent use of pre‐emptive versus empirical antifungal therapy in people with cancer who have FN. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013604-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013604-sec-0014"></div> <p>To assess the relative efficacy, safety, and impact of antifungal agent use of pre‐emptive versus empirical antifungal therapy in people with cancer who have febrile neutropenia. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013604-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013604-sec-0015"></div> <section id="CD013604-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013604-sec-0017"> <h4 class="title">Types of studies</h4> <p>We only included studies with a randomised controlled trial (RCT) design that compared pre‐emptive antifungal therapy with empirical antifungal therapy for people with cancer, in which participants were prospectively identified. Our eligibility criteria included cluster‐randomised and cross‐over trials. We did not include quasi‐randomised (i.e. using a method of allocation that is not truly random) or non‐randomised comparative studies.  </p> </section> <section id="CD013604-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included studies with adults, 18 years or older, with cancer, who had febrile neutropenia (FN) as a result of chemotherapy or bone marrow transplantation. We did not restrict participants for gender, ethnicity, underlying malignancies (e.g. solid tumours, haematological malignancies, or haematopoietic stem cell recipients), or the type of chemotherapy used. We also included studies with a paediatric population (younger than 18 years), as long as it was less than 33.3% of the total population of the trial. </p> <p>We defined fever as a single oral temperature reading above 38.3 °C (101 °F), or a temperature above 38.0 °C (100.4 °F) that was sustained for at least one hour; and neutropenia as an absolute neutrophil count (ANC) of 500 cells/mm³ or less, or an ANC that was expected to decrease to less than 500 cells/mm³ during the next 48 hours (<a href="./references#CD013604-bbs2-0022" title="FreifeldAG , BowEJ , SepkowitzKA , BoeckhMJ , ItoJI , MullenCA , et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clinical Infectious Diseases2011;52(4):e56-93.">Freifeld 2011</a>). When studies used alternative definitions, we included such studies, provided their definitions meant the same as ours.  </p> </section> <section id="CD013604-sec-0019"> <h4 class="title">Types of interventions</h4> <section id="CD013604-sec-0020"> <h5 class="title">Experimental intervention</h5> <p>Pre‐emptive antifungal therapy referred to treatment that started only when diagnostic tests explicitly suggested the presence of a fungal infection during FN. To investigate the fungal infection, studies were to have used a serological test (e.g. blood β‐D‐glucan, blood galactomannan antigen, serum <i>Candida spp</i> . or <i>Aspergillus spp</i>. detected by polymerase chain reaction (PCR)), an imaging study (e.g. chest X‐ray or pulmonary or sinus computed tomography (CT)), or both. </p> </section> <section id="CD013604-sec-0021"> <h5 class="title">Comparison interventions</h5> <p>Empirical antifungal therapy referred to treatment with broad‐spectrum antibacterials that was initiated after several consecutive days of persistent FN. </p> <p>If studies used alternative definitions, we included such studies, provided their definitions meant the same as ours. </p> </section> </section> <section id="CD013604-sec-0022"> <h4 class="title">Types of outcome measures</h4> <p>We evaluated one primary outcome and five secondary outcomes.</p> <section id="CD013604-sec-0023"> <h5 class="title">Primary outcomes</h5> <p>We considered all‐cause mortality as the primary outcome (survival period was defined as the time interval from random treatment assignment to either death from any cause or the last follow‐up). </p> <p>We did not separate the primary outcome data into short‐ (2 to 6 weeks), medium‐ (7 to 16 weeks), and long‐term (17 to 48 weeks) mortality (<a href="./references#CD013604-bbs2-0027" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3. (updated February 2022) Cochrane, 2022 . Available from www.training.cochrane.org/handbook.">Higgins 2022</a>). When possible, we also estimated mortality that occurred during hospitalisation. </p> </section> <section id="CD013604-sec-0024"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD013604-list-0001"> <li> <p>Treatment failure</p> <ol id="CD013604-list-0002"> <li> <p>Mortality ascribed to fungal infection: defined as death with clinical or autopsy diagnosis of refractory invasive fungal disease (IFD), in the absence of other causes </p> </li> </ol> </li> <li> <p>Other outcomes</p> <ol id="CD013604-list-0003"> <li> <p>Proportion of antifungal agent use (other than prophylactic use), defined as the proportion of study participants who received antifungal agents other than prophylactic use during the study period. </p> </li> <li> <p>Duration of antifungal agent use (days)</p> </li> <li> <p>Invasive fungal infection detection, defined according to the criteria of the European Organization for Research and Treatment of Cancer/Mycoses Study Group, when available (<a href="./references#CD013604-bbs2-0012" title="AsciogluS , RexJH , dePauwB , BennettJE , BilleJ , CrokaertF , et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clinical Infectious Diseases2002;34(1):7-14.">Ascioglu 2002</a>; <a href="./references#CD013604-bbs2-0019" title="DonnellyJP , ChenSC , KauffmanCA , SteinbachWJ , BaddleyJW , VerweijPE , et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clinical Infectious Diseases2020;71(6):1367-76. [DOI: 10.1093/cid/ciz1008]">Donnelly 2020</a>; <a href="./references#CD013604-bbs2-0018" title="De PauwB , WalshTJ , DonnellyJP , StevensDA , EdwardsJE , CalandraT , et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clinical Infectious Diseases2008;46(12):1813-21.">De Pauw 2008</a>) </p> </li> <li> <p>Adverse events (e.g. treatment discontinuation, nephrotoxicity, hepatic dysfunction), according to the Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0 2017, when available (<a href="./references#CD013604-bbs2-0036" title="Natinal Cancer Instittute. Common terminology criteria for adverse events (CTCAE) v5.0. Available at ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm Nov 2017 (Last access date: 19 August 2022).">National Cancer Institiute 2017</a>) </p> </li> </ol> </li> </ol> </p> <p>We prepared a summary of findings table that reported the following outcomes, listed in order of priority. </p> <p> <ol id="CD013604-list-0004"> <li> <p>All‐cause mortality</p> </li> <li> <p>Mortality ascribed to fungal infection</p> </li> <li> <p>Proportion of antifungal agent use (other than prophylactic use)</p> </li> <li> <p>Duration of antifungal agent use</p> </li> <li> <p>Invasive fungal infection detection</p> </li> <li> <p>Adverse events</p> </li> </ol> </p> </section> </section> </section> <section id="CD013604-sec-0025"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD013604-sec-0026"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases:</p> <p> <ul id="CD013604-list-0005"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2021, Issue 10) in the Cochrane Library (searched 12 October 2021; <a href="./appendices#CD013604-sec-0076">Appendix 1</a>); </p> </li> <li> <p>MEDLINE Ovid (1946 to September week 5 2021; <a href="./appendices#CD013604-sec-0077">Appendix 2</a>); </p> </li> <li> <p>Embase Ovid (1980 to 2021 week 40; <a href="./appendices#CD013604-sec-0078">Appendix 3</a>); </p> </li> <li> <p>PubMed (1966 to October 2021).</p> </li> </ul> </p> <p>We searched trial databases, specifically current controlled trials in the National Institutes of Health database (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov/</a>), for ongoing and unpublished trials. </p> </section> <section id="CD013604-sec-0027"> <h4 class="title">Searching other resources</h4> <p>We reviewed the references of all included studies for additional trials. We handsearched the following conference proceedings: </p> <p> <ul id="CD013604-list-0006"> <li> <p>European Congress of Clinical Microbiology and Infectious Diseases (2001 to Oct 2021);</p> </li> <li> <p>Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and American Society of Mircrobiology (ASM) Microbe (2001 to Oct 2021); </p> </li> <li> <p>Annual Meeting of the Infectious Diseases Society of America (IDSA) and ID Week (2001 to Oct 2021); </p> </li> <li> <p>European Society for Medical Oncology Congress (2001 to Oct 2021);</p> </li> <li> <p>American Society of Clinical Oncology Annual Meeting (2001 to Oct 2021); and</p> </li> <li> <p>American Society of Haematology (ASH) Annual Meeting (2001 to Oct 2021).</p> </li> </ul> </p> </section> </section> <section id="CD013604-sec-0028"> <h3 class="title" id="CD013604-sec-0028">Data collection and analysis</h3> <section id="CD013604-sec-0029"> <h4 class="title">Selection of studies</h4> <p>We downloaded all titles and abstracts retrieved by electronic searching into <a href="https://www.covidence.org/sign_in" target="_blank">Covidence</a> and removed duplicates. Two review authors (YU and HI) independently screened the titles and abstracts, and excluded those that clearly did not meet the following inclusion criteria: </p> <p> <ol id="CD013604-list-0007"> <li> <p>Is the study described as an RCT?</p> </li> <li> <p>Does the study compare pre‐emptive therapy with empirical therapy?</p> </li> <li> <p>Were the participants identified as people with cancer?</p> </li> </ol> </p> <p>We obtained full‐text copies of any potentially relevant references and assessed the eligibility of the retrieved articles. We resolved any disagreement through discussion, or, if required, we consulted a third person (YM). We identified and excluded duplicate reports and collated multiple reports of the same study, so that each study rather than each report was the unit of interest in the review. We recorded the selection process in sufficient detail to complete a PRISMA flow diagram and the characteristics of included and excluded studies tables (<a href="./references#CD013604-bbs2-0035" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of Internal Medicine2009;151(4):264-9.">Moher 2009</a>). </p> </section> <section id="CD013604-sec-0030"> <h4 class="title">Data extraction and management</h4> <p>The same review authors (YU and HI) designed a data extraction form (<a href="./appendices#CD013604-sec-0079">Appendix 4</a>). We extracted the following information and data. </p> <p> <ul id="CD013604-list-0008"> <li> <p>General information (i.e. title, authors, contact information, country, language and year of publication, sponsors and conflict of interests) </p> </li> <li> <p>Trial characteristics (e.g. study design, inclusion and exclusion criteria, publication status, study years, number of centres, randomisation procedure, allocation concealment, blinding procedure, early termination, completeness of data, presence of selective reporting, assessment of compliance, handling of withdrawals, losses to follow‐up, type of analysis, and presence of other sources of bias) </p> </li> <li> <p>Participant characteristics (i.e. type of population, inclusion and exclusion criteria, and baseline characteristics) </p> </li> <li> <p>Information regarding the intervention (i.e. what test was used before the antifungal drug administration started) </p> </li> <li> <p>Information regarding outcomes (e.g. all‐cause mortality, mortality ascribed to fungal infection, IFD detection, proportion of antifungal agent use (other than prophylactic use), adverse events, cost, and other reported outcomes) </p> </li> <li> <p>All individuals randomised in the outcome assessment, preferably by intention‐to‐treat; when a single study provided data for multiple measures of the same outcome, we chose the measure that best fit our outcome definitions </p> </li> <li> <p>For dichotomous outcomes, we recorded the number of participants manifesting the outcome in each group, as well as the number of evaluated participants per group </p> </li> <li> <p>For continuous outcomes, we documented values as well as the measure chosen to report data (e.g. mean with standard deviation (SD) and median with interquartile range) </p> </li> </ul> </p> <p>The two review authors (YU and HI) entered the collected data into the Review Manager 5 file (RevMan 5 (<a href="./references#CD013604-bbs2-0038" title="Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.">Review Manager 2020</a>)). We double‐checked if the data were entered correctly by comparing the data in RevMan 5 with the study reports. A third review author (YM) independently reviewed the extracted data for accuracy, and resolved any disagreements. </p> </section> <section id="CD013604-sec-0031"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The two authors (YU and HI) independently assessed risk of bias in each study by using the following items: </p> <p> <ul id="CD013604-list-0009"> <li> <p>selection bias (random sequence generation and allocation concealment),</p> </li> <li> <p>performance bias (blinding of participants and personnel),</p> </li> <li> <p>detection bias (blinding of outcome assessment),</p> </li> <li> <p>attrition bias (incomplete outcome data; defined as high risk when the number of randomised participants was not provided, or the outcome reported was less than 80% of the randomised population without justification), </p> </li> <li> <p>reporting bias (selective reporting), and other biases.</p> </li> </ul> </p> <p>We expressed the classification of the specific risks of bias as low, high, or unclear risk of bias, using the criteria suggested in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013604-bbs2-0026" title="HigginsJPT , AltmanDG , SterneJAC , editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017. Available from training.cochrane.org/handbook/PDF/v5.2/chapter-08.">Higgins 2017</a>). We resolved any disagreement by discussion. We detailed the risk of bias assessment in the <a href="./references#CD013604-sec-0088" title="">Characteristics of included studies</a> table, and graphically presented the results in risk of bias summary tables. </p> </section> <section id="CD013604-sec-0032"> <h4 class="title">Measures of treatment effect</h4> <p>For continuous outcomes, we extracted means with SD from the studies. If reported differently in a trial, we contacted the trial authors to request the means and SD. We computed the mean difference (MD) and the 95% confidence intervals (CI) for each study. For all dichotomous outcomes, we calculated the risk ratios (RR) for individual studies, with 95% CI. We did not plan to analyse time‐to‐event data (e.g. hazard ratios). </p> </section> <section id="CD013604-sec-0033"> <h4 class="title">Unit of analysis issues</h4> <p>We presented the included studies in a parallel‐group design; the unit of analysis was expected to be the individual participant. If we included cluster‐randomised trials, we planned to use the published effect estimates, with clustering taken into account. When the original report correctly analysed the cluster‐randomised study, we planned to enter the effect estimate and standard error, using the generic inverse‐variance method in RevMan 5. </p> <p>If the original report failed to adjust for cluster effects, we planned to include the studies only when we could extract the following information: </p> <p> <ul id="CD013604-list-0010"> <li> <p>number of clusters randomised to each intervention, or the average size of each cluster,</p> </li> <li> <p>outcome data, ignoring the cluster design, for the total number of participants, and</p> </li> <li> <p>estimate of the intracluster correlation coefficient (ICC).</p> </li> </ul> </p> <p>We planned to use the ICC from similarly designed studies when such were available. Then, we planned to conduct the approximately correct analysis following the procedures described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013604-bbs2-0027" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3. (updated February 2022) Cochrane, 2022 . Available from www.training.cochrane.org/handbook.">Higgins 2022</a>). If multiple‐arm trials were included, we planned to consider within‐study correlation, by calculating the average of the relevant pairwise comparisons from the study, and calculating a variance for the study, accounting for the correlation between the comparisons. If the control group was a common comparator in a comparison, we planned to divide the participants by the number of relevant intervention groups, to avoid double counting the same data. For trials that had a cross‐over design, we planned to only consider results from the first randomisation period, to avoid period effects. </p> </section> <section id="CD013604-sec-0034"> <h4 class="title">Dealing with missing data</h4> <p>We requested missing information from the study authors, but were not successful in all cases. The primary analysis was an intention‐to‐treat analysis (ITT), wherein all participants randomised to treatment were included in the denominator. This analysis assumed that all losses to follow‐up had favourable outcomes. To explore the impact of the missing data on the summary effect estimate for death, we planned to conduct a sensitivity analysis.  </p> <p>If the data were not available for an ITT analyses, we analysed the data with a per‐protocol approach. We described and critiqued any methods, such as imputation, reported in the publication to address incomplete data. In the discussion section of the review, we considered the impact of missing data on the review findings. If possible, we planned to impute missing SDs from other reported studies, by using the maximum reported values in those studies. In all cases, we considered the most conservative assumptions. </p> </section> <section id="CD013604-sec-0035"> <h4 class="title">Assessment of heterogeneity</h4> <p>We tested for statistical heterogeneity between trials by using the Chi² test (P &lt; 0.1 was considered statistically significant), and the I² statistic, along with a visual inspection of the forest plots. We interpreted I² values in accordance with the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013604-bbs2-0027" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3. (updated February 2022) Cochrane, 2022 . Available from www.training.cochrane.org/handbook.">Higgins 2022</a>). An approximate guide to interpretation was: </p> <p> <ul id="CD013604-list-0011"> <li> <p>0% to 40% might not be important;</p> </li> <li> <p>30% to 60% may represent moderate heterogeneity;</p> </li> <li> <p>50% to 90% may represent substantial heterogeneity;</p> </li> <li> <p>75% to 100% indicates considerable heterogeneity.</p> </li> </ul> </p> <p>We also kept in mind that the importance of the observed value in the I² statistic depends on the magnitude and direction of effects and the strength of evidence for heterogeneity.  We conducted subgroup and sensitivity analyses if the I² was above 50%. </p> </section> <section id="CD013604-sec-0036"> <h4 class="title">Assessment of reporting biases</h4> <p>Had we pooled more than 10 studies, we planned to proceed with the relevant statistical test for funnel plot asymmetry to explore possible small study biases. Since we pooled fewer than 10 trials, we included a narrative description of the risk of reporting bias. </p> </section> <section id="CD013604-sec-0037"> <h4 class="title">Data synthesis</h4> <p>We analysed the data using RevMan 5 (<a href="./references#CD013604-bbs2-0038" title="Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.">Review Manager 2020</a>). We individually combined included studies in a meta‐analysis. Given the nature of the intervention, we used a random‐effects model. When we detected substantial and considerable heterogeneity (I² &gt; 75%), we investigated potential source of the heterogeneity and downgraded the evidence. </p> <p>For dichotomous data, we pooled RRs by using the Mantel–Haenszel method. For continuous data, we calculated the mean difference (MD) when data were reported using the same scale, or standardised mean difference (SMD) for data reported in different scales. We reported pooled estimates with 95% CI. </p> </section> <section id="CD013604-sec-0038"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We pre‐planned and addressed the following potential effect modifiers of the primary outcome (all‐cause mortality).  </p> <p> <ul id="CD013604-list-0012"> <li> <p>documented infection (clinically or microbiologically) versus fever of unknown aetiology</p> </li> <li> <p>high‐risk participants versus low‐risk participants, preferably defined by a Multinational Association for Supportive Care (MASCC) score, but we accepted and documented the study definitions </p> </li> <li> <p>people with solid tumour versus people with haematological malignancy</p> </li> <li> <p>severity of neutropenia (ANC &lt; 100 cells/mm³ versus ANC between 100 cells/mm³ and 500 cells/mm³), referring to the lowest ANC documented (nadir of neutropenia) </p> </li> <li> <p>anti‐mould prophylaxis versus non‐anti‐mould prophylaxis</p> </li> <li> <p>selection of antifungal agents</p> </li> <li> <p>people undergoing stem‐cell transplantation versus people undergoing chemotherapy (we expected stem‐cell transplantation) </p> </li> </ul> </p> </section> <section id="CD013604-sec-0039"> <h4 class="title">Sensitivity analysis</h4> <p>We planned sensitivity analyses for the primary outcome, based on risk bias (only including data from trials at low risk of bias); missing data (only including data from trials without missing data), and the presence of heterogeneity (only including data from trials with homogenous interventions). We added sensitivity analyses for all‐cause mortality reported in the short‐term (2 to 6 weeks), and medium‐term (7 to 16 weeks). Since <a href="./references#CD013604-bbs2-0004" title="HebartH ,  KlingsporL ,  KlingebielT ,  LoefflerJ ,  TollemarJ ,  LjungmanP ,  et al. A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT. Bone Marrow Transplant2009;43(7):553-61. [DOI: 10.1038/bmt.2008.355]">Hebart 2009</a> reported all‐cause mortality at both short‐ and medium‐term time points, we added another sensitivity analysis in which we replaced medium‐term data for short‐term data. </p> </section> <section id="CD013604-sec-0040"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We presented the overall certainty of the evidence for each outcome according to the GRADE approach, which took into account issues related to internal validity (risk of bias, inconsistency, imprecision, publication bias), and external validity, such as directness of results (<a href="./references#CD013604-bbs2-0029" title="LangendamMW , AklEA , DahmP , GlasziouP , GuyattG , SchunemannHJ . Assessing and presenting summaries of evidence in Cochrane Reviews. Systematic Reviews2013;23(2):81.">Langendam 2013</a>; <a href="./references#CD013604-bbs2-0040" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , GuyattGH , on behalf of the Cochrane Applicability and Recommendations Methods Group and the Cochrane Statistical Methods Group. Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Schünemann 2011</a>). We created a summary of findings table, following the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013604-bbs2-0027" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3. (updated February 2022) Cochrane, 2022 . Available from www.training.cochrane.org/handbook.">Higgins 2022</a>), using <a href="./references#CD013604-bbs2-0025" title="GRADEpro GDT. Version Accessed October 2021. Hamilton (ON): McMaster University (developed by Evidence Prime), 2021. Available at gradepro.org.">GRADEPro GDT</a> software. We downgraded the evidence from high certainty by one level for serious (or by two for very serious) concerns for each limitation. We used the GRADE approach and GRADE Working Group certainty of evidence definitions, listed below (<a href="./references#CD013604-bbs2-0034" title="MeaderN , KingK , LlewellynA , NormanG , BrownJ , RodgersM , et al. A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation. Systematic Reviews2014;3(1):82.">Meader 2014</a>).  </p> <p> <ul id="CD013604-list-0013"> <li> <p>High certainty: we are very confident that the true effect lies close to that of the estimate of the effect. </p> </li> <li> <p>Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> </li> <li> <p>Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect. </p> </li> <li> <p>Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </li> </ul> </p> <p>We evaluated the evidence for all‐cause mortality, mortality ascribed to fungal infection, proportion of antifungal agent use (other than prophylactic use), duration of antifungal use (days), invasive fungal infection detection, and adverse effects, for the comparison between empirical antifungal therapy and pre‐emptive antifungal therapy. </p> <p>Since we were unable to undertake meta‐analysis for all outcomes, we presented our results in a hybrid summary of findings table format (both quantitative and narrative), such as that used by <a href="./references#CD013604-bbs2-0014" title="ChanRJ , WebsterJ ,  MarquartL . Information interventions for orienting patients and their carers to cancer care facilities. Cochrane Database of Systematic Reviews2011, Issue 12. Art. No: CD008273. [DOI: 10.1002/14651858.CD008273.pub2]">Chan 2011</a>. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013604-sec-0041" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013604-sec-0041"></div> <section id="CD013604-sec-0042"> <h3 class="title">Description of studies</h3> <section id="CD013604-sec-0043"> <h4 class="title">Results of the search</h4> <p>We retrieved 2254 reports from the systematic literature search, one abstract from an academic conference, and two studies by handsearching. After <a href="./references#CD013604-bbs2-0017" title="Covidence. Version accessed October 2021. Melbourne, Australia: Veritas Health Innovation, 2021. Available at covidence.org.">Covidence</a> removed 174 duplicate records, we screened 2083 records. We unanimously included seven records after title and abstract screening, and two after discussing 19 conflict points. We assessed the full text of nine reports for eligibility (<a href="#CD013604-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD013604-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA flow diagram, illustrating study selection" data-id="CD013604-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA flow diagram, illustrating study selection</p> </div> </div> </div> </section> <section id="CD013604-sec-0044"> <h4 class="title">Included studies</h4> <p>We included seven trials included in the review. See <a href="./references#CD013604-sec-0088" title="">Characteristics of included studies</a> for details.  </p> <p>The included studies only enroled 1480 people with high‐risk febrile neutropenia (FN; e.g. people with haematological malignancy); none with low‐risk FN (e.g. people with solid tumour). We found variability in the definition of pre‐emptive treatment (e.g. laboratory tests with or without quantitative real‐time PCR assays, ELISA, galactomannan test; imaging with or without high‐resolution computed tomography; prophylaxis; antifungal agents). Three were single‐centred, and four were multicentre trials. </p> </section> <section id="CD013604-sec-0045"> <h4 class="title">Excluded studies</h4> <p>We excluded two reports after full‐text review, and described the reasons in the <a href="./references#CD013604-sec-0089" title="">Characteristics of excluded studies</a>; one had the wrong intervention, and one was not a randomised trial.  </p> </section> </section> <section id="CD013604-sec-0046"> <h3 class="title">Risk of bias in included studies</h3> <p>For details of the risk of bias judgements for each study, see <a href="./references#CD013604-sec-0088" title="">Characteristics of included studies</a>. See <a href="#CD013604-fig-0002">Figure 2</a> for the graphical representation of the overall risk of bias across included studies. </p> <div class="figure" id="CD013604-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD013604-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> </div> <section id="CD013604-sec-0047"> <h4 class="title">Allocation</h4> <p><b>Sequence generation</b><br/>Four studies described the method of randomisation in detail (low risk of bias); three did not, and the process was unclear (unclear risk of bias). </p> <p><b>Allocation concealment</b><br/>Appropriate allocation concealment was performed in five studies (low risk of bias), and the process was unclear in two studies that did not provide a detailed description (unclear risk of bias). </p> </section> <section id="CD013604-sec-0048"> <h4 class="title">Blinding</h4> <p><b>Blinding of participants and personnel</b> </p> <p>Blinding of participants, healthcare professionals, and investigators was not feasible due to the nature of the intervention. Non‐blinded or open label was clearly stated in four studies, and not in three studies (high risk of bias). </p> <p><b>Blinding of outcome assessment</b> </p> <p>Five of the seven studies reported a blinded outcome assessor, so we assessed them at low risk of bias; we assessed the other two as unclear risk of bias, because of lack of information. </p> </section> <section id="CD013604-sec-0049"> <h4 class="title">Incomplete outcome data</h4> <p>All studies clearly stated the process from participant enrolment to allocation and outcome assessment (low risk of bias), but there was a serious risk of bias in <a href="./references#CD013604-bbs2-0002" title="BlennowO ,  RembergerM ,  KlingsporL ,  OmazicB ,  FranssonK ,  LjungmanP ,  et al. Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT. Bone Marrow Transplant2010;45(12):1710-8. [DOI: 10.1038/bmt.2010.38]">Blennow 2010</a>; only 21 out of 41 enroled people were randomised (high risk of bias). </p> </section> <section id="CD013604-sec-0050"> <h4 class="title">Selective reporting</h4> <p>Four studies had clinical trial registration. We did not identify any apparent selective reporting, and judged them at low risk of bias. Since there were no protocols or clinical trial registrations for the other three studies, we rated them at unclear risk of bias. </p> </section> <section id="CD013604-sec-0051"> <h4 class="title">Other potential sources of bias</h4> <p>Five studies transparently described the study process, and we did not identify other potential biases (low risk of bias). The other two studies lacked sufficient information to assess other biases (unclear risk of bias). </p> </section> </section> <section id="CD013604-sec-0052"> <h3 class="title" id="CD013604-sec-0052">Effects of interventions</h3> <p>See: <a href="./full#CD013604-tbl-0001"><b>Summary of findings 1</b> Pre‐emptive antifungal therapy versus empirical antifungal therapy</a> </p> <p>See: <a href="./full#CD013604-tbl-0001">summary of findings Table 1</a> </p> <p>Six included studies reported the effect on all‐cause mortality; five reported on mortality ascribed to fungal infection; seven reported on the proportion of antifungal agent use (other than prophylactic use); three reported on the duration of antifungal use in days; seven reported on invasive fungal infection detection; and four reported adverse events.  </p> <section id="CD013604-sec-0053"> <h4 class="title">Primary outcome</h4> <section id="CD013604-sec-0054"> <h5 class="title">All‐cause mortality</h5> <p>There may be little to no difference between groups for all‐cause mortality (risk ratio (RR) 0.97, 95% confidence interval (CI) 0.72 to 1.30; absolute effect – reduction of 3 out of 1000; 6 studies, 1459 participants; low‐certainty evidence; <a href="./references#CD013604-fig-0003" title="">Analysis 1.1</a>). No evidence of heterogeneity was identified for this outcome (Chi² = 3.31, I² = 0%).  </p> </section> </section> <section id="CD013604-sec-0055"> <h4 class="title">Secondary outcomes</h4> <section id="CD013604-sec-0056"> <h5 class="title">Mortality ascribed to fungal infection</h5> <p>There may be little to no difference between groups for mortality ascribed to fungal infection (RR 0.92, 95% CI 0.45 to 1.89; absolute effect – reduction of 2 out of 1000; 5 studies, 1407 participants; low‐certainty evidence; <a href="./references#CD013604-fig-0004" title="">Analysis 1.2</a>). No evidence of heterogeneity was identified for this outcome (Chi² = 4.48, I² = 11%).  </p> </section> <section id="CD013604-sec-0057"> <h5 class="title">Proportion of antifungal agent use (other than prophylactic use)</h5> <p>Pre‐emptive therapy may reduce the proportion of antifungal agent used (other than prophylactic use; RR 0.71, 95% CI 0.47 to 1.05; absolute effect – reduction of 125 out of 1000; 7 studies, 1480 participants; very low‐certainty evidence: <a href="./references#CD013604-fig-0005" title="">Analysis 1.3</a>). There was considerable heterogeneity for this outcome (Chi² = 49.0, I² = 88%); intervention protocols for antifungal agents used were heterogeneous across included studies.  </p> </section> <section id="CD013604-sec-0058"> <h5 class="title">Duration of antifungal use (days)</h5> <p>Pre‐emptive therapy may reduce the duration of antifungal use more than empirical therapy (mean difference (MD) ‐3.52 days, 95% CI ‐6.99 to ‐0.66; 3 studies, 764 participants; very low‐certainty evidence; <a href="./references#CD013604-fig-0006" title="">Analysis 1.4</a>). There was considerable heterogeneity for this outcome (Chi² = 14.64, I² = 86%).  </p> </section> <section id="CD013604-sec-0059"> <h5 class="title">Invasive fungal infection detection</h5> <p> Pre‐emptive therapy may increase invasive fungal infection detection more than empirical treatment (RR 1.70, 95% CI 0.71 to 4.05; absolute effect – increased by 43 out of 1000; 7 studies, 1480 participants; very low‐certainty evidence; <a href="./references#CD013604-fig-0007" title="">Analysis 1.5</a>). There was considerable heterogeneity for this outcome (Chi² = 23.54, I² = 75%).  </p> </section> <section id="CD013604-sec-0060"> <h5 class="title">Adverse events</h5> <p>Four of the seven trials reported adverse events. Since the adverse events and evaluating methods were different among the trials, we did not undertake a meta‐analysis. Narrative summary of the adverse events follows. </p> <p><a href="./references#CD013604-bbs2-0004" title="HebartH ,  KlingsporL ,  KlingebielT ,  LoefflerJ ,  TollemarJ ,  LjungmanP ,  et al. A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT. Bone Marrow Transplant2009;43(7):553-61. [DOI: 10.1038/bmt.2008.355]">Hebart 2009</a> reported 39/152 (25.7%) cases of nephrotoxicity in the pre‐emptive therapy group, and 28/92 (30.4%) cases in the empirical therapy group.  </p> <p><a href="./references#CD013604-bbs2-0005" title="MorrisseyCO , ChenSC , SorrellTC , MillikenS , BardyPG , BradstockKF , et al,  Australasian Leukaemia Lymphoma Group and the Australia and New Zealand Mycology Interest Group. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. Lancet Infectious Diseases2013;13(6):519-28. [DOI: 10.1016/S1473-3099(13)70076-8]">Morrissey 2013</a> reported 12/118 (10%) cases of hepatotoxicity in the pre‐emptive therapy group, and 21/122 (17%; P = 0.11) in the empirical therapy group. They also reported 60/118 (51%) cases of nephrotoxicity in the pre‐emptive therapy group, and 52/122 (43%; P = 0.21) in the empirical therapy group.  </p> <p>In <a href="./references#CD013604-bbs2-0003" title="CordonnierC , PautasC , MauryS , VekhoffA , FarhatH , SuarezF , et al. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial. Clinical Infectious Diseases2009;48(8):1042-51. ">Cordonnier 2009</a>, the mean decrease of creatinine clearance ± standard deviation (SD) was larger in the empirical therapy group (‐8.7 ± 20.8) than in the pre‐emptive therapy group (‐5.8 ± 27.2). Severe adverse events occurred in similar proportions among the two groups.  </p> <p>In <a href="./references#CD013604-bbs2-0007" title="YuanW ,  RenJ ,  GuoX ,  Xiaoling Guo,  CaiS . Preemptive antifungal therapy for febrile neutropenic hematological malignancy patients in China. Medical Science Monitor2016;22:4226-32. [DOI: 10.12659/msm.897596]">Yuan 2016</a>, 1/26 courses (3.8%) of antifungal treatment administered during pre‐emptive therapy, and 2/43 courses (4.7%) of empirical therapy led to adverse events, for which antifungal treatment was discontinued (P = 0.874). </p> </section> <section id="CD013604-sec-0061"> <h5 class="title">Subgroup analysis</h5> <p>We had planned a number of subgroup analyses for the primary outcome (prophylaxis, cancer type, risk of FN, selection of antifungal agents, severity of neutropenia, type of chemotherapy), but the reports all lacked sufficient information to enable us to do so. Our enquiries to corresponding authors of each of the studies did not garner enough data. Therefore, we did not perform any subgroup analyses. </p> </section> <section id="CD013604-sec-0062"> <h5 class="title">Sensitivity Analysis</h5> <p>Results were consistent for all‐cause mortality when we excluded data from trials with higher risk of bias (<a href="./references#CD013604-fig-0008" title="">Analysis 2.1</a>); replaced medium‐term with short‐term outcome data for <a href="./references#CD013604-bbs2-0004" title="HebartH ,  KlingsporL ,  KlingebielT ,  LoefflerJ ,  TollemarJ ,  LjungmanP ,  et al. A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT. Bone Marrow Transplant2009;43(7):553-61. [DOI: 10.1038/bmt.2008.355]">Hebart 2009</a> (<a href="./references#CD013604-fig-0009" title="">Analysis 2.2</a>), or separately analysed short‐term (2 to 6 weeks; <a href="./references#CD013604-fig-0010" title="">Analysis 2.3</a>), and medium‐term (7 to 16 weeks) outcome data (<a href="./references#CD013604-fig-0011" title="">Analysis 2.4</a>).  </p> <p>We were unable to undertake sensitivity analyses for trials with no missing data, or those with homogenous interventions, as planned, due to lack of data. </p> </section> <section id="CD013604-sec-0063"> <h5 class="title">Reporting bias</h5> <p>We did use a funnel plot to assess reporting bias because we only included seven trials. It was difficult to fully evaluate reporting bias, because not all trials had clinical trial registrations, and published protocols. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013604-sec-0064" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013604-sec-0064"></div> <section id="CD013604-sec-0065"> <h3 class="title" id="CD013604-sec-0065">Summary of main results</h3> <p>See <a href="./full#CD013604-tbl-0001">summary of findings Table 1</a>  for the comparison, pre‐emptive versus empirical antifungal therapy for febrile neutropenia in people with cancer. </p> <p>We included seven randomised controlled trials, with 1480 participants in this review. </p> <p>There may be little to no difference between groups for all‐cause mortality (risk ratio (RR) 0.97, 95% confidence interval (CI) 0.72 to 1.30); and mortality ascribed to fungal infection (RR 0.92, 95% CI 0.45 to 1.89).  </p> <p>Pre‐emptive therapy may decrease antifungal agent use (other than prophylactic use; RR 0.71, 95% CI 0.47 to 1.05); and the duration of antifungal use (mean difference (MD) ‐3.52, 95% CI ‐6.99 to ‐0.06) over pre‐emptive therapy.  </p> <p>Although we could not undertake a meta‐analysis of adverse events, narratively, there seemed to be no apparent difference in the frequency or severity of adverse events between groups. </p> </section> <section id="CD013604-sec-0066"> <h3 class="title" id="CD013604-sec-0066">Overall completeness and applicability of evidence</h3> <p>Our conclusions were based on data from seven studies that met our inclusion criteria. We completed sensitivity analyses for the primary outcome, all‐cause mortality, for risk of bias and measurement time point. We found that these results were consistent with the primary analysis, which supported the robustness of the effect. We were unable to complete our pre‐planned subgroup analysis, due to lack of data.  </p> <p>Each study used their own specific antifungal protocols for both pre‐emptive and empirical antifungal therapies. The results from this review were based on clinically heterogeneous evidence, and did not provide a clear answer as to which protocol should be implemented in clinical practice.  </p> <p>The two outcomes associated with mortality exhibited less statistically heterogeneity, suggesting that whatever protocol chosen may have little impact on mortality. The two outcomes of clinical resource utilisation, and the identification rate of invasive fungal disease (IFD) showed considerable statistical heterogeneity (I<sup>2</sup> &gt; 75%), which might reflect the effects of different intervention and outcome evaluation protocols. </p> </section> <section id="CD013604-sec-0067"> <h3 class="title" id="CD013604-sec-0067">Quality of the evidence</h3> <p>We judged all seven of the included studies to have some risk of bias, in particular, none of the participants or personnel were blinded. We downgraded the certainty of the evidence for all outcomes by one level due to lack of blinding. We identified non‐negligible clinical and statistical heterogeneity for each outcome, which was a critical factor of indirectness, for which we downgraded the certainty by another level, or two (for serious indirectness). Since we were unable to pool the data for adverse events, we downgraded by another level for sparse data. </p> </section> <section id="CD013604-sec-0068"> <h3 class="title" id="CD013604-sec-0068">Potential biases in the review process</h3> <p>First, our literature search strategy seemed have limited sensitivity. Although it was not specified in the title and abstract as pre‐emptive treatment, there were studies that conceptually, could be regarded as pre‐emptive treatment (<a href="./references#CD013604-bbs2-0002" title="BlennowO ,  RembergerM ,  KlingsporL ,  OmazicB ,  FranssonK ,  LjungmanP ,  et al. Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT. Bone Marrow Transplant2010;45(12):1710-8. [DOI: 10.1038/bmt.2010.38]">Blennow 2010</a>; <a href="./references#CD013604-bbs2-0005" title="MorrisseyCO , ChenSC , SorrellTC , MillikenS , BardyPG , BradstockKF , et al,  Australasian Leukaemia Lymphoma Group and the Australia and New Zealand Mycology Interest Group. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. Lancet Infectious Diseases2013;13(6):519-28. [DOI: 10.1016/S1473-3099(13)70076-8]">Morrissey 2013</a>). These studies were included in a previous review by <a href="./references#CD013604-bbs2-0023" title="FungM , KimJ , MartyFM , SchwarzingerM , KooS . Meta-analysis and cost comparison of empirical versus pre-emptive antifungal strategies in hematologic malignancy patients with high-risk febrile neutropenia. PLoS One2015;10(11):e0140930. [DOI: 10.1371/journal.pone.0140930]">Fung 2015</a>; we identified them by handsearching. </p> <p>Second, we were unable to conduct subgroup analyses. Efficacy of pre‐emptive treatment can be modified by various factors, including our pre‐planned factors. Since subgroup analysis contributes to the identification of suitable treatment populations, future studies would be encouraged to report the results of various subgroup analysis in detail. </p> <p>Third, we meta‐analysed various evaluation periods for the primary endpoints. Initially, we planned analyses for short‐term, medium‐, and long‐term outcomes, but we only had seven trials. The main analysis had low statistical heterogeneity, but the short‐term and medium‐term evaluations, as sensitivity analysis, had higher statistical heterogeneity. It would be reasonable to develop a consensus on the clinically optimal evaluation period. </p> <p>Finally, the novel concept of antifungal treatment strategy for FN has been developed in recent years. <a href="./references#CD013604-bbs2-0008" title="KandaY , KimuraSI , IinoM , FukudaT , SakaidaE , OyakeT , et al,  Japan Febrile Neutropenia Study Group. D-index-guided early antifungal therapy versus empiric antifungal therapy for persistent febrile neutropenia: a randomized controlled noninferiority trial. Journal of Clinical Oncology 2020 Mar 10;38(8):815-22. [DOI: 10.1200/JCO.19.01916]">Kanda 2020</a> developed D‐Index‐Guided Early Antifungal Therapy and demonstrated promising efficacy. When we update the current review, it will be necessary to update the review questions, including not only a comparison between pre‐emptive and experiential therapy, but also the novel treatment strategies.  </p> </section> <section id="CD013604-sec-0069"> <h3 class="title" id="CD013604-sec-0069">Agreements and disagreements with other studies or reviews</h3> <p><a href="./references#CD013604-bbs2-0023" title="FungM , KimJ , MartyFM , SchwarzingerM , KooS . Meta-analysis and cost comparison of empirical versus pre-emptive antifungal strategies in hematologic malignancy patients with high-risk febrile neutropenia. PLoS One2015;10(11):e0140930. [DOI: 10.1371/journal.pone.0140930]">Fung 2015</a> conducted a systematic review and meta‐analysis of the same research question as this review in 2015, which included nine studies: five RCTs, and four non‐RCT study designs. We included these five RCTs, and we also added two further studies. </p> <p>They concluded that "Compared to empirical antifungal therapy, pre‐emptive strategies were associated with significantly lower antifungal exposure (RR 0.48, 95% CI 0.27 to 0.85) and duration, without an increase in IFD‐related mortality (RR 0.82, 95% CI 0.36 to 1.87) or overall mortality (RR 0.95, 95% CI 0.46 to 1.99)". Our results were similar. The statistical heterogeneity associated with mortality improved in our review, which may be due to the focus on randomised controlled trials and the addition of new studies. Both reviews showed considerable statistical heterogeneity in IFD identification and antifungal agent use. The duration of antifungal use was only meta‐analysed in our review. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013604-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/urn:x-wiley:14651858:media:CD013604:CD013604-FIG-01" target="_blank"><b></b></a></p> </div><img alt="PRISMA flow diagram, illustrating study selection" data-id="CD013604-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_t/tCD013604-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA flow diagram, illustrating study selection</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/full#CD013604-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013604-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/urn:x-wiley:14651858:media:CD013604:CD013604-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD013604-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_t/tCD013604-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/full#CD013604-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013604-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/urn:x-wiley:14651858:media:CD013604:CD013604-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Pre‐emptive versus empirical antifungal therapy, Outcome 1: All‐cause mortality" data-id="CD013604-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_t/tCD013604-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Pre‐emptive versus empirical antifungal therapy, Outcome 1: All‐cause mortality </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/references#CD013604-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013604-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/urn:x-wiley:14651858:media:CD013604:CD013604-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Pre‐emptive versus empirical antifungal therapy, Outcome 2: Mortality ascribed to fungal infection" data-id="CD013604-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_t/tCD013604-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Pre‐emptive versus empirical antifungal therapy, Outcome 2: Mortality ascribed to fungal infection </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/references#CD013604-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013604-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/urn:x-wiley:14651858:media:CD013604:CD013604-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Pre‐emptive versus empirical antifungal therapy, Outcome 3: Proportion of antifungal agent use (other than prophylactic use)" data-id="CD013604-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_t/tCD013604-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Pre‐emptive versus empirical antifungal therapy, Outcome 3: Proportion of antifungal agent use (other than prophylactic use) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/references#CD013604-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013604-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/urn:x-wiley:14651858:media:CD013604:CD013604-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Pre‐emptive versus empirical antifungal therapy, Outcome 4: Duration of antifungal use (days)" data-id="CD013604-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_t/tCD013604-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Pre‐emptive versus empirical antifungal therapy, Outcome 4: Duration of antifungal use (days) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/references#CD013604-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013604-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/urn:x-wiley:14651858:media:CD013604:CD013604-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Pre‐emptive versus empirical antifungal therapy, Outcome 5: Invasive fungal infection detection" data-id="CD013604-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_t/tCD013604-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Pre‐emptive versus empirical antifungal therapy, Outcome 5: Invasive fungal infection detection </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/references#CD013604-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013604-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/urn:x-wiley:14651858:media:CD013604:CD013604-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Sensitivity analyses for all‐cause mortality, Outcome 1: RCTs at lower risk of bias" data-id="CD013604-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_t/tCD013604-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Sensitivity analyses for all‐cause mortality, Outcome 1: RCTs at lower risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/references#CD013604-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013604-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/urn:x-wiley:14651858:media:CD013604:CD013604-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Sensitivity analyses for all‐cause mortality, Outcome 2: Replacing outcomes for Hebart 2009" data-id="CD013604-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_t/tCD013604-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Sensitivity analyses for all‐cause mortality, Outcome 2: Replacing outcomes for Hebart 2009 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/references#CD013604-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013604-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/urn:x-wiley:14651858:media:CD013604:CD013604-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Sensitivity analyses for all‐cause mortality, Outcome 3: Short‐term time point" data-id="CD013604-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_t/tCD013604-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Sensitivity analyses for all‐cause mortality, Outcome 3: Short‐term time point </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/references#CD013604-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013604-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/urn:x-wiley:14651858:media:CD013604:CD013604-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Sensitivity analyses for all‐cause mortality, Outcome 4: Medium‐term time point" data-id="CD013604-fig-0011" src="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_t/tCD013604-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Sensitivity analyses for all‐cause mortality, Outcome 4: Medium‐term time point </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/references#CD013604-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/media/CDSR/CD013604/image_n/nCD013604-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013604-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Pre‐emptive antifungal therapy versus empirical antifungal therapy</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Pre‐emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population</b>: people with cancer who have febrile neutropenia </p> <p><b>Settings</b>: intensive cytotoxic chemotherapy at hospital </p> <p><b>Intervention</b>: pre‐emptive antifungal therapy </p> <p><b>Comparison</b>: empirical antifungal therapy </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcome</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk with empirical antifungal therapy</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk with pre‐emptive antifungal therapy</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>108 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>105 per 1000 (78 to 141)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.97 (0.72 to 1.30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1459<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕◯◯</p> <p>low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality ascribed to fungal infection</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>27 per 1000 (13 to 55)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.92 (0.45 to 1.89)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1407<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕◯◯</p> <p>low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Proportion of antifungal agent use (other than prophylactic use)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>431 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>306 per 1000 (202 to 452)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.71 (0.47 to 1.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1480<br/>(7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕◯◯◯</p> <p>very low<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Duration of antifungal use</b>  </p> <p><i>(days)</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of antifungal use ranged across control groups from</p> <p>7 to 20 days</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of antifungal use ranged across intervention groups from</p> <p>4.5 to 13.8 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐3.52 (‐6.99 to ‐0.66)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>764<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕◯◯◯</p> <p>very low<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Invasive fungal infection detection</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>60 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>103 per 1000 (43 to 244)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.70 (0.71 to 4.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1480<br/>(7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕◯◯◯</p> <p>very low<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD013604-bbs2-0004" title="HebartH ,  KlingsporL ,  KlingebielT ,  LoefflerJ ,  TollemarJ ,  LjungmanP ,  et al. A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT. Bone Marrow Transplant2009;43(7):553-61. [DOI: 10.1038/bmt.2008.355]">Hebart 2009</a> reported 39/152 (25.7%) cases of nephrotoxicity in the pre‐emptive therapy group, and 28/92 cases (30.4%) in the empirical therapy group.  </p> <p><a href="./references#CD013604-bbs2-0005" title="MorrisseyCO , ChenSC , SorrellTC , MillikenS , BardyPG , BradstockKF , et al,  Australasian Leukaemia Lymphoma Group and the Australia and New Zealand Mycology Interest Group. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. Lancet Infectious Diseases2013;13(6):519-28. [DOI: 10.1016/S1473-3099(13)70076-8]">Morrissey 2013</a> reported 12/118 (10%) cases of hepatotoxicity in the pre‐emptive therapy group, and 21/122 (17%; P = 0.11) cases in the empirical therapy group; and 60/118 (51%) cases of nephrotoxicity in the pre‐emptive therapy group, and 52/122 (43%; P = 0.21) cases in the empirical therapy group.  </p> <p><a href="./references#CD013604-bbs2-0003" title="CordonnierC , PautasC , MauryS , VekhoffA , FarhatH , SuarezF , et al. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial. Clinical Infectious Diseases2009;48(8):1042-51. ">Cordonnier 2009</a> reported the mean decrease in creatinine clearance ± SD was larger in the empirical therapy group (‐8.7 ± 20.8) than in the pre‐emptive therapy group (‐5.8 ± 27.2). Severe adverse events occurred in similar proportions in the two groups.  </p> <p><a href="./references#CD013604-bbs2-0007" title="YuanW ,  RenJ ,  GuoX ,  Xiaoling Guo,  CaiS . Preemptive antifungal therapy for febrile neutropenic hematological malignancy patients in China. Medical Science Monitor2016;22:4226-32. [DOI: 10.12659/msm.897596]">Yuan 2016</a> reported that 1/26 courses (3.8%) of antifungal treatment resulted in adverse events leading to discontinued treatment in the pre‐emptive therapy group, and 2/43 courses (4.7%) resulted in adverse events leading to discontinued treatment in the empirical therapy group (P = 0.874). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1074 </p> <p>(4 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕◯◯◯</p> <p>very low<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the intervention group and the relative effect of the intervention (and its 95% CI). </p> <p>CI: confidence interval; RR: risk ratio; MD, mean difference.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded the certainty of the evidence by two levels. First, since there were no blinded studies, this could lead to considerable risk of bias; second, the clinical heterogeneity of the interventions was a critical factor of indirectness. <br/><sup>b</sup>We downgraded the certainty of the evidence by three levels. First, since there were no blinded studies, this could lead to considerable risk of bias; second, the clinical heterogeneity of the interventions was critical factor of indirectness; third, the results were inconsistent, marked with considerable heterogeneity (I<sup>2</sup> =75% to 88%). <br/><sup>c</sup>We downgraded the certainty of the evidence by three levels. First, since there were no blinded studies, this could lead to considerable risk of bias; second, the clinical heterogeneity of the interventions was critical factor of indirectness; third, meta analysis was not performed.  </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Pre‐emptive antifungal therapy versus empirical antifungal therapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/full#CD013604-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013604-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Pre‐emptive versus empirical antifungal therapy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1459</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.72, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Mortality ascribed to fungal infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1407</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.45, 1.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Proportion of antifungal agent use (other than prophylactic use) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1480</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.47, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Duration of antifungal use (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>764</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.52 [‐6.99, ‐0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Invasive fungal infection detection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1480</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [0.71, 4.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Pre‐emptive versus empirical antifungal therapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/references#CD013604-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013604-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Sensitivity analyses for all‐cause mortality</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 RCTs at lower risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1191</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.68, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Replacing outcomes for Hebart 2009 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1459</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.52, 1.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Short‐term time point <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>964</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.25, 3.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Medium‐term time point <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>455</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.65, 1.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Sensitivity analyses for all‐cause mortality</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013604.pub2/references#CD013604-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013604.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD013604-note-0012">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013604-note-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013604-note-0011">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD013604-note-0008">Hrvatski</a> </li> <li class="section-language"> <a class="" href="id#CD013604-note-0009">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="ko#CD013604-note-0005">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD013604-note-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="th#CD013604-note-0006">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013604-note-0003">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD013604-note-0004">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013604\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013604\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013604\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013604\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013604\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013604\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013604\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013604\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013604\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013604\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013604\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013604\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013604\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013604\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013604\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013604\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013604\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013604\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013604.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013604.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013604.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013604.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013604.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727370323"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013604.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727370327"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013604.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918eaa6a9ec79377',t:'MTc0MDcyNzM3MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 